Assessment of Quitting Versus Using Aspirin Therapy In Patients Treated With Oral Anticoagulation for Atrial Fibrillation or Other Indication With Stabilized Coronary Artery Disease
Latest Information Update: 21 Jan 2025
At a glance
- Drugs Apixaban (Primary) ; Aspirin (Primary) ; Dabigatran etexilate (Primary) ; Rivaroxaban (Primary)
- Indications Coronary artery disease; Coronary thrombosis; Stroke
- Focus Adverse reactions; Therapeutic Use
- Acronyms AQUATIC
Most Recent Events
- 16 Jan 2025 Status changed from recruiting to discontinued.
- 12 Jun 2023 Planned End Date changed from 1 Apr 2024 to 1 May 2028.
- 12 Jun 2023 Planned primary completion date changed from 1 Apr 2024 to 1 May 2028.